Department of Orthodontics, School and Hospital of Stomatology, Hubei-MOST KLOS & KLOBM, Wuhan University, Wuhan, China.
School of Dentistry, University of Dundee, Dundee, United Kingdom.
Am J Orthod Dentofacial Orthop. 2021 Nov;160(5):659-670.e7. doi: 10.1016/j.ajodo.2021.04.018. Epub 2021 Aug 6.
The objective was to identify and summarize the outcomes and evaluation methods used in clinical trials regarding the prevention and treatment of orthodontically induced white spot lesions (WSLs).
Three electronic databases were searched to identify studies that were (1) clinical trials on prevention and/or treatment of orthodontically induced WSLs, (2) reported in English, and (3) published between January 2010 and October 2019. At least 2 authors assessed the eligibility and extracted the characteristics, outcomes, and evaluation methods from included studies. All disagreements were resolved through discussion.
Among 1328 studies identified, 51 were eligible and included. A total of 48 different outcomes and 11 different evaluation methods were used in these studies. The most frequently used outcomes were WSLs clinical visual examination scores (n = 22, 43.1%), DIAGNOdent values (n = 14; 27.5%), fluorescence loss measured with quantitative light-induced fluorescence (QLF) (n = 10; 19.6%), and lesion area measured with QLF (n = 10; 19.6%). The most frequently used evaluation methods were clinical examination (n = 25; 49.0%), visual inspection by photographs (n = 15; 29.4%), DIAGNOdent (n = 14; 27.5%), and QLF (n = 10; 19.6%). None of the included studies reported data on quality of life.
Substantial outcome heterogeneity exists among studies regarding the prevention and treatment of orthodontically induced WSLs. Most of the identified outcomes are aimed to assess morphologic changes of WSLs and may not reflect patient perspectives.
The Core Outcome Set for trials on the prevention and treatment of enamel White Spot Lesions (COS-WSL) project was registered in the COMET Initiative database (No. 1399).
本研究旨在识别和总结有关正畸诱导的白色 spots 病变(WSLs)预防和治疗的临床试验中的结局和评估方法。
通过三个电子数据库检索了(1)预防和/或治疗正畸诱导的 WSLs 的临床试验,(2)用英语报告,(3)发表于 2010 年 1 月至 2019 年 10 月之间的研究。至少有两位作者评估了纳入研究的合格性,并提取了特征、结局和评估方法。所有分歧均通过讨论解决。
在 1328 项研究中,有 51 项符合条件并被纳入。这些研究共使用了 48 种不同的结局和 11 种不同的评估方法。最常使用的结局是 WSLs 临床视觉检查评分(n=22,43.1%)、DIAGNOdent 值(n=14;27.5%)、定量光诱导荧光(QLF)测量的荧光损失(n=10;19.6%)和 QLF 测量的病变面积(n=10;19.6%)。最常使用的评估方法是临床检查(n=25;49.0%)、照片视觉检查(n=15;29.4%)、DIAGNOdent(n=14;27.5%)和 QLF(n=10;19.6%)。纳入的研究均未报告关于生活质量的数据。
正畸诱导的 WSLs 预防和治疗研究中存在大量结局的异质性。大多数确定的结局旨在评估 WSLs 的形态变化,可能无法反映患者的观点。
预防和治疗釉质白色 spots 病变(COS-WSL)项目的临床试验核心结局集(COS-WSL)已在 COMET 倡议数据库中注册(编号 1399)。